Castle Lon, Aubert Ronald E, Verbrugge Robert R, Khalid Mona, Epstein Robert S
Medco Health Solutions Inc., 100 Parsons Pond Drive, Franklin Lakes, NJ 07417, USA.
J Atten Disord. 2007 May;10(4):335-42. doi: 10.1177/1087054707299597.
This study examines demographic trends in the use of medications to treat ADHD in adult and pediatric populations.
Using pharmacy claims data for a large population of commercially insured Americans, the study measures ADHD treatment prevalence and drug use from 2000 to 2005.
In 2005, 4.4% of children (ages 0 to 19) and 0.8% of adults (ages 20 and older) used ADHD medications. Treatment rates were higher in boys (6.1%) than in girls (2.6%), but the rates for men and women were approximately equal (0.8%). During the period of the study, treatment prevalence increased rapidly (11.8% per year) for the population as a whole. Treatment rates grew more rapidly for adults than for children, more rapidly for women than for men, and more rapidly for girls than for boys.
Improved identification of ADHD in adult and female patients has contributed to rapid growth in ADHD medication use.
本研究调查了成人和儿童群体中使用药物治疗注意力缺陷多动障碍（ADHD）的人口统计学趋势。
该研究利用大量商业保险美国人的药房报销数据，测量了2000年至2005年期间ADHD的治疗患病率和药物使用情况。
2005年，4.4%的儿童（0至19岁）和0.8%的成人（20岁及以上）使用ADHD药物。男孩的治疗率（6.1%）高于女孩（2.6%），但男性和女性的治疗率大致相等（0.8%）。在研究期间，总体人群的治疗患病率迅速上升（每年11.8%）。成人的治疗率增长速度快于儿童，女性快于男性，女孩快于男孩。
成人和女性患者中ADHD识别率的提高导致了ADHD药物使用的快速增长。
